Archives: Speakers

Laura is a perceptive, versatile, results-oriented and proven clinical operations leader with a passion for patient and site experience, access to healthcare, and co-creating the future of clinical research. Leveraging deep experience in study delivery, people leadership and development, and data-driven insights, she believes that the cores of leadership are curiosity and service.

Dr. Peter Schmidt is a neuroscientist with a wealth of experience in biomedical research. He’s been an inventor, principal investigator, and mathematician with experience in neurology, psychiatry, and immunology. Before joining Rho, he was the Vice Dean at East Carolina University’s Brody School of Medicine, where he oversaw research and clinical care. During his time at the Parkinson’s Foundation, Dr. Schmidt designed and led the largest clinical study of Parkinson’s disease, enrolling 12,000 patients across 30 academic medical centers in five countries. He has served in advisory and board roles for national and international organizations in clinical care, research, and patient advocacy including the National Quality Forum, the Cystic Fibrosis Foundation, and the Huntington’s Study Group. He holds two patents and has authored many peer-reviewed journal articles.

Dr. Andrew Feigin is a neurologist with over 30 years of experience. Throughout his career, he’s made groundbreaking contributions to neurology and clinical research. After a fellowship in experimental therapeutics, Dr. Feigin joined North Shore University Hospital as an assistant professor of neurology. There, he set up a clinical trial program for Parkinson’s, Huntington’s, Tourette syndrome, dystonia and other movement disorders. Subsequently, Dr. Feigin joined the NYU Grossman School of Medicine as Professor of Neurology where he directed the Fresco Institute for Parkinson’s and Movement Disorders. He’s been the site principal investigator for over 30 clinical trials, and a global PI for several multicenter clinical trials including the first phase 1 gene therapy trial for Parkinson’s and several large multicenter trials for Huntington’s disease. Dr. Feigin has pursued independent research developing imaging biomarkers for neurodegenerative disorders, and he has published over 150 peer-reviewed articles. He’s a member of prestigious organizations including the American Academy of Neurology, the American Neurological Association, and the Movement Disorder Society, and he has served on numerous advisory boards, steering committees, DSMB’s, and NIH and foundation review committees.

Chris is a RTSM Solutions Specialist at Medidata with over 25 years of experience in Clinical Research specialising in Randomisation and Trial Supply Management (RTSM). He began his career at Clinphone working as a programmer and has held various Technical and Project related roles at Technology Vendors and CROs. With his vast experience and knowledge, he has a great understanding of what it takes to efficiently work with Sponsors and to help them select and develop systems. Chris is a graduate of Nottingham Trent University and holds a Bachelors of Science degree in Physics and Computer Science.

An advocate of change, specifically change within our energy system and landscape which creates a more sustainable and equitable tomorrow.

Andrew strongly believes in the need to infuse data and digitalisation with systems and infrastructure to enable a sustainable global transition to a low carbon economy.

Working for over 20 years within the engineering sector, Andrew has held programme and account management positions throughout his career and more recently lead a data services practice for Siemens throughout EMEA before joining SI-B and leading the Sustainability division within GB&I.

Passionate about decarbonisation and the sustainable transformation of the energy system. More than 25 years of international experience as manager, advisor, business developer, strategist, project manager and trainer in energy efficiency, sustainability, and international development cooperation. Background in energy engineering with a PhD on energy efficiency from the University of Aachen. Authored and co-authored several publications and books on energy efficiency in the industrial sector and on climate change policy topics.

Harminder specializes in research in the Power, Renewable Energy and Smart Grid sectors. He has more than 20 years of experience, most of which has been in energy sector research.

At GlobalData, Harminder manages research and analysis in the Power sector and is responsible for the company’s Power Intelligence Center.

He has led a large number of studies in the power and renewable energy sectors covering various aspects, including generation, transmission, distribution, smart grids, equipment, power trading, tariffs, policy and regulatory aspects, etc.

Thomas Seeber is the Director – Data Center Power Generation. He holds an Electrical Engineering degree, a Bachelor’s in Management & Economics, and a Master’s in International Business. In his previous roles, Thomas served as the Global Warranty Leader for Jenbacher gas engines, Service Product Manager for GE Distributed Power’s Type 6 gas engine platform before he decided 7 years ago to join the global sales organization of INNIO Jenbacher, where he currently is Director of Global Technical Sales.

Markus Strömich-Jenewein, Director of Commercial Strategy & Business Development at INNIO Group is responsible for developing and implementing the commercial strategy for the Jenbacher brand, including the Jenbacher H2-Engine platforms. As a seasoned sales professional, he focuses on identifying and capitalizing on opportunities in the global energy landscape, particularly in decentralized hydrogen-based energy solutions. Markus also serves on INNIO Group’s Sustainability Board and has been with the organization since 2007. He holds a master’s degree in international management from the University of Applied Sciences in Graz, Austria.